222 related articles for article (PubMed ID: 32991075)
1. In Vitro Permeation Test (IVPT) for Pharmacokinetic Assessment of Topical Dermatological Formulations.
Santos LL; Swofford NJ; Santiago BG
Curr Protoc Pharmacol; 2020 Dec; 91(1):e79. PubMed ID: 32991075
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous Pharmacokinetics of Acyclovir Cream 5% Products: Evaluating Bioequivalence with an In Vitro Permeation Test and an Adaptation of Scaled Average Bioequivalence.
Shin SH; Rantou E; Raney SG; Ghosh P; Hassan H; Stinchcomb A
Pharm Res; 2020 Oct; 37(10):210. PubMed ID: 33001286
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Skin Permeation Methodology for Over-The-Counter Topical Dermatologic Products.
Oh L; Yi S; Zhang D; Shin SH; Bashaw E
Ther Innov Regul Sci; 2020 May; 54(3):693-700. PubMed ID: 33301148
[TBL] [Abstract][Full Text] [Related]
4. Relating transdermal delivery plasma pharmacokinetics with in vitro permeation test (IVPT) findings using diffusion and compartment-in-series models.
Liu X; Anissimov YG; Grice JE; Cheruvu HS; Ghosh P; Raney SG; Maibach HI; Roberts MS
J Control Release; 2021 Jun; 334():37-51. PubMed ID: 33857564
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics-Based Approaches for Bioequivalence Evaluation of Topical Dermatological Drug Products.
Raney SG; Franz TJ; Lehman PA; Lionberger R; Chen ML
Clin Pharmacokinet; 2015 Nov; 54(11):1095-106. PubMed ID: 26063051
[TBL] [Abstract][Full Text] [Related]
6. Detailed pharmacokinetic characterization of advanced topical acyclovir formulations with IVPT and in vivo Open Flow Microperfusion.
Schwagerle G; Sharp MJ; Parr A; Schimek D; Mautner SI; Birngruber T
Int J Pharm; 2023 Aug; 643():123269. PubMed ID: 37495025
[TBL] [Abstract][Full Text] [Related]
7. The Sensitivity of In Vitro Permeation Tests to Chemical Penetration Enhancer Concentration Changes in Fentanyl Transdermal Delivery Systems.
Shin SH; Srivilai J; Ibrahim SA; Strasinger C; Hammell DC; Hassan HE; Stinchcomb AL
AAPS PharmSciTech; 2018 Oct; 19(7):2778-2786. PubMed ID: 30084070
[TBL] [Abstract][Full Text] [Related]
8. Method to determine the impact of substantivity on ex vivo skin-permeation.
Schmidberger M; Daniels R; Lunter DJ
Eur J Pharm Biopharm; 2018 Oct; 131():1-7. PubMed ID: 30048744
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic Modeling of In Vitro Skin Permeation and Extrapolation to In Vivo for Topically Applied Metronidazole Drug Products Using a Physiologically Based Pharmacokinetic Model.
Arora S; Clarke J; Tsakalozou E; Ghosh P; Alam K; Grice JE; Roberts MS; Jamei M; Polak S
Mol Pharm; 2022 Sep; 19(9):3139-3152. PubMed ID: 35969125
[TBL] [Abstract][Full Text] [Related]
10. Diffusion modelling of percutaneous absorption kinetics. Predicting urinary excretion from in vitro skin permeation tests (IVPT) for an infinite dose.
Liu X; Yousef S; Anissimov YG; van der Hoek J; Tsakalozou E; Ni Z; Grice JE; Roberts MS
Eur J Pharm Biopharm; 2020 Apr; 149():30-44. PubMed ID: 32018051
[TBL] [Abstract][Full Text] [Related]
11. Effect of Controlled Heat Application on Topical Diclofenac Formulations Evaluated by In Vitro Permeation Tests (IVPT) Using Porcine and Human Skin.
Thomas S; Shin SH; Hammell DC; Hassan HE; Stinchcomb AL
Pharm Res; 2020 Feb; 37(3):49. PubMed ID: 32034502
[TBL] [Abstract][Full Text] [Related]
12. A Comparative Evaluation of Desoximetasone Cream and Ointment Formulations Using Experiments and In Silico Modeling.
Matharoo NS; Garimella HT; German C; Przekwas AJ; Michniak-Kohn B
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894801
[TBL] [Abstract][Full Text] [Related]
13. An advanced automation platform coupled with mass spectrometry for investigating in vitro human skin permeation of UV filters and excipients in sunscreen products.
Zhang J; Yang Y; Ashraf M; Cruz CN; Lee S; Faustino PJ
Rapid Commun Mass Spectrom; 2022 Jun; 36(11):e9273. PubMed ID: 35178789
[TBL] [Abstract][Full Text] [Related]
14. In vitro-in vivo correlations for nicotine transdermal delivery systems evaluated by both in vitro skin permeation (IVPT) and in vivo serum pharmacokinetics under the influence of transient heat application.
Shin SH; Thomas S; Raney SG; Ghosh P; Hammell DC; El-Kamary SS; Chen WH; Billington MM; Hassan HE; Stinchcomb AL
J Control Release; 2018 Jan; 270():76-88. PubMed ID: 29175139
[TBL] [Abstract][Full Text] [Related]
15. In vitro studies into establishing therapeutic bioequivalence of complex topical products: Weight of evidence.
Miranda M; Volmer Z; Cornick A; Goody A; Cardoso C; Pais AACC; Brown M; Vitorino C
Int J Pharm; 2024 May; 656():124012. PubMed ID: 38537923
[TBL] [Abstract][Full Text] [Related]
16. Influence of cryopreservation methods of ex vivo rat and pig skin on the results of in vitro permeation test.
Ling J; Du Y; Sheng Y; Wang W; Wu H; Chen G; Lv H
Eur J Pharm Biopharm; 2023 Aug; 189():109-121. PubMed ID: 37327914
[TBL] [Abstract][Full Text] [Related]
17. Topical delivery of acyclovir and ketoconazole.
Jacobs GA; Gerber M; Malan MM; du Preez JL; Fox LT; du Plessis J
Drug Deliv; 2016; 23(2):631-41. PubMed ID: 25005585
[TBL] [Abstract][Full Text] [Related]
18. Use of an in vitro human skin permeation assay to assess bioequivalence of two topical cream formulations containing butenafine hydrochloride (1%, w/w).
Mitra A; Kim N; Spark D; Toner F; Craig S; Roper C; Meyer TA
Regul Toxicol Pharmacol; 2016 Dec; 82():14-19. PubMed ID: 27816671
[TBL] [Abstract][Full Text] [Related]
19. In vitro and ex-vivo evaluation of topical formulations designed to minimize transdermal absorption of Vitamin K1.
Nabiee R; Dubois B; Green L; Sharma A; Wong SF; Montazeri Aliabadi H
PLoS One; 2018; 13(10):e0204531. PubMed ID: 30289881
[TBL] [Abstract][Full Text] [Related]
20. Understanding Formulation and Temperature Effects on Dermal Transport Kinetics by IVPT and Multiphysics Simulation.
Zambrana PN; Hou P; Hammell DC; Li T; Stinchcomb AL
Pharm Res; 2022 May; 39(5):893-905. PubMed ID: 35578064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
